MedTrace Logo

Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects

NCT00874757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-08-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see whether Statin drugs will act as anti-inflammatories. The investigators will study this potential anti-inflammatory activity in healthy subjects.

Conditions

  • Healthy

Interventions

DRUG

Rosuvastatin

Healthy subjects received rosuvastatin 20 mg orally for 3 weeks. Inflammatory markers measured pre- and post- rosuvastatin treatment.

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Timothy R McGuire, PharmD · University of Nebraska

Eligibility

Min Age
19 Years
Max Age
39 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-15
Primary Completion
2011-09-01
Completion
2011-09-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874757 on ClinicalTrials.gov